Mesoblast
MESO
$8.52
Share price
4.28%
Change (1 day)
134.71%
Change (1 year)
Categories
Mesoblast (MESO) - Total debt
Total debt on the balance sheet as of December 2023 : $0.12 B
According to Mesoblast 's latest financial reports the company's total debt is $0.12 B. A company’s total debt is the sum of all current and non-current debts.
Mesoblast - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-06-30 | $0.11 B | 8.97% |
| 2022-06-30 | $0.10 B | 1.34% |
| 2021-06-30 | $0.10 B | 6.22% |
| 2020-06-30 | $99.31 M | 22.18% |
| 2019-06-30 | $81.28 M | 36.85% |
| 2018-06-30 | $59.39 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.8 M | -99.34% | Bahamas |
 NRC Health
NRC | $42.07 M | -65.51% | 🇺🇸 USA |